Press Releases

BOSTON, May 15, 2024 /PRNewswire/ -- Capstone Partners, a leading middle market investment banking firm, released its inaugural 2024 Women Entrepreneurs Study, which analyzes the responses of more than 200 female business owners across the U.S. for key findings related to business decisions, growth strategies, and legacy expectations. By comparing the survey results to Capstone's annual Middle Market (MM) Business Owners Survey, the report seeks to identify and... (continue reading...)

Miami, Florida, May 15, 2024 (GLOBE NEWSWIRE) -- Miami, FL – South Florida PBS Health Channel’s new original production, Ask the Doc: No Appointment Needed, is an engaging interactive series that simplifies healthcare by bringing medical professionals right into your living room. This series premieres on Monday, May 20th at 12:30 PM on the Health Channel and will stream live on AllHealthGo’s Facebook and YouTube channels.

This innovative series invites... (continue reading...)

PaxMedica (OTC: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has filed a formal notice of appeal with the NASDAQ Office of Appeals and Review; the company is appealing to reverse the decision of the NASDAQ Hearings Panel to delist the company from. The company also announced that it has retained Jacob Frenkel, Dickinson Wright, PLLC as its lead counsel in the appeal. According to the announcement, PaxMedica believes the... (continue reading...)

LONDON, 15 May. 2024 (GLOBE NEWSWIRE) -- This is the End of Day Message for GlobeNewswire.

GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information provider.

Disclaimer

The content and accuracy of all information distributed through Notified is wholly the responsibility of the originator. Notified accepts no liability for any losses arising from reliance by any person upon the content of any announcement.

If you... (continue reading...)

Allucent Will Conduct New Decentralized Phase IV Study Aimed at Counteracting Future Coronavirus Strains and Variants 

CARY, N.C., May 15, 2024 /PRNewswire/ -- Allucent, a global mid-sized clinical research organization (CRO), announced today that it received a project award valued at $25.5 million through the Rapid Response Partnership Vehicle (RRPV) Consortium to conduct its Decentralized Home Focus COVID-19 Trial. The RRPV is a consortium funded by the ... (continue reading...)